Measurement of tumor hypoxia in spontaneous canine sarcomas

Vet Radiol Ultrasound. 2005 Jul-Aug;46(4):348-54. doi: 10.1111/j.1740-8261.2005.00065.x.

Abstract

We used positron emission tomography (PET) with [18F]fluoromisonidazole ([18F]FMISO) to study tumor hypoxia in six dogs with spontaneous sarcomas. The tumors were regarded as hypoxic if [18F]FMISO uptake exceeded normal tissue radioactivity by 40% (tumor/muscle ratio > 1.4) or if kinetic analysis indicated a positive [18F]FMISO tissue influx rate (Ki > 0) by a Patlak plot. Using these criteria, we found hypoxia in a fibrosarcoma grade II, an undifferentiated sarcoma, and an ostoeosarcoma, but not in a fibrosarcoma grade I, another osteosarcoma, and a myxosarcoma. In three animals, the tumor oxygen partial pressure (pO2) was also measured invasively using Eppendorf needle electrodes. In these cases, the Eppendorf measurements were confirmed by the [18F]FMISO PET results. In addition, [15O]H2O PET was performed in four dogs in order to assess tumor perfusion. Comparisons of the [18F]FMISO with [15O]H2O PET images in two cases showed that tumor hypoxia occurred in the tumor center with low perfusion, whereas perfusion was heterogeneous in a nonhypoxic tumor.

MeSH terms

  • Animals
  • Blood Gas Monitoring, Transcutaneous
  • Dog Diseases / metabolism*
  • Dogs
  • Fluorine Radioisotopes / pharmacokinetics
  • Hypoxia / metabolism
  • Hypoxia / veterinary*
  • Misonidazole / analogs & derivatives*
  • Misonidazole / pharmacokinetics
  • Positron-Emission Tomography*
  • Radiation-Sensitizing Agents / pharmacokinetics*
  • Sarcoma / classification
  • Sarcoma / metabolism
  • Sarcoma / veterinary*

Substances

  • Fluorine Radioisotopes
  • Radiation-Sensitizing Agents
  • fluoromisonidazole
  • Misonidazole